- A Pilot Study of Fluorodeoxyglucose Positron Emission Tomography Findings in Patients with Phenylketonuria before and during Sapropterin Supplementation
-
Ficicioglu C, Dubroff JG, Thomas N, Gallagher , Burfield J, Hussa C, Randall R, Zhuang H
- KMID: 2287553
- J Clin Neurol.
- 2013 Jul;9(3):151-156.
- doi: 10.3988/jcn.2013.9.3.151
BACKGROUND AND PURPOSE: PET scanning with fluorodeoxyglucose (FDG-PET) is a non-invasive method that measures regional glucose metabolic rate. Phenylalanine (Phe) and its metabolites appear to impair several aspects of brain... -
- CITED
-
- Close
- SHARE
-
- Close
